Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity
SEOUL, South Korea, Sept. 19, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology, "MuCT™". This is a real-time PCR based data acquiring and analyzing technology that increases its multiplexing capability per...
Seegene Will Unveil Combination Test at ECCMID 2018
SEOUL, South Korea, April 17, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, announced that it will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases ("ECCMID 2018") taking place inMadrid, Spain, from April 21 to ...
Seegene develops world's first multiplex MDx assays with its AI system
SEOUL, South Korea, Jan. 3, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced today that, utilizing a newly created artificial intelligence ("AI") based assay development system, the company succeeded in develop...
Unique concept of MDx, Seegene Random Access System, announced at AACC 2017
SEOUL, South Korea, July 26, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the "System") at the 69th AACC Annual Clinical Lab Expo in San Diego, CA,...
Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific
SEOUL, South Korea, May 22, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific in which Seegene w...
Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific
SEOUL, South Korea, May 22, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific in which Seegene w...
Seegene Unlocks the Door to the Next Level of the Real-time PCR Business
SEOUL, South Korea, April 26, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that it is entering into more innovative and powerful business realm by developing the Second-generation Real-time PCR Technology which has been recently pat...
Seegene to Introduce Automated Development of in silico-based Multiplex Real-time PCR Assays
SEOUL, South Korea, Aug. 3, 2016 /PRNewswire/ -- Seegene, Inc. (096530.KQ), a leading developer of multiplex real-time PCR technologies announced that it has introduced the world's first automated development ofin silico-based multiplex real-time PCR assays. Real-time PCR is the best method for ...
Biodist and Seegene Establish Joint Venture in Mexico
SEOUL, South Korea, April 5, 2016 /PRNewswire/ -- Biodist SA de CV., a leader in molecular solutions inMexico, and Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies in Korea, are establishing a Joint Venture ("JV") inMexico to target the Mexico and central and southern A...
